Market revenue in 2023 | USD 93.5 million |
Market revenue in 2030 | USD 142.6 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Roche Holding AG ADR, Qiagen NV, Siemens Healthineers AG ADR, Becton Dickinson & Co, Illumina Inc, Epigenomics AG, Koninklijke Philips NV, FUJIFILM Holdings Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liver cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 61.93% in 2023. Horizon Databook has segmented the Mexico liver cancer diagnostics market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico accounted for the second largest market share in terms of revenue in 2019. This growth can be attributed to high mortality rates associated with liver cancer, which has led to an increase in demand for efficient diagnostic products for early diagnosis of the diseases.
In Mexico, the main risk factors for Hepatocellular Carcinoma (HCC), the most common type of primary liver cancer, are HCV and high alcohol consumption. According to a national survey on drug use, conducted by the Mexican government, binge drinking alcohol has increased significantly in Mexico, leading to inflammation and scarring of the liver, thereby increasing the risk of liver cancer.
Thus, demand for diagnostics solutions in the country is growing. Furthermore, rising medical tourism in Mexico due to cost-effective healthcare services is also anticipated to drive the demand for novel liver cancer diagnostics solutions.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico liver cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Mexico liver cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account